Iradimed Corp (OQ:IRMD)

Oct 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30th. IRADIMED management will host a conference call the same day beginning at...
Oct 08, 2019 07:00 am ET
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter. “The resolution of the warning letter is the result...
Aug 27, 2019 04:15 pm ET
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer, will participate in the Morgan Stanley...
Jul 30, 2019 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results
iRadimed Corporation (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Jul 29, 2019 04:00 pm ET
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step down as President and CEO on August 19, 2019...
Jul 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, July 30th. iRadimed management will host a conference call the same day beginning at...
Apr 30, 2019 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
iRadimed Corporation (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Apr 16, 2019 07:00 am ET
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30th.  IRADIMED management will host a conference call the same day beginning at...
Apr 11, 2019 07:15 am ET
Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion Financial, iRadimed, and Stewart Information Services — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Noble Energy Inc. (NYSE:NBL), American Vanguard Corporation (NYSE:AVD),...
Apr 02, 2019 07:00 am ET
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2”) monitoring features of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient...
Feb 06, 2019 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Jan 22, 2019 07:10 am ET
IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th
IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market opens on Wednesday, February 6th. IRADIMED management will host a conference call the same day beginning...
Jan 22, 2019 07:00 am ET
IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue After Temporarily Suspending Shipments of MRI Compatible Patient Vital Signs Monitoring Systems in European Markets
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices today announced that it temporarily suspended sales of its 3880 MRI compatible patient vital signs monitoring systems...
Dec 19, 2018 07:00 am ET
IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced FDA 510(k) clearance of its 3883 MRI-compatible invasive blood pressure module for use with its 3880...
Nov 16, 2018 07:20 am ET
New Research Coverage Highlights Beasley Broadcast Group, Resolute Energy, Hanger, Inspired Entertainment, Saratoga Investment, and iRadimed — Consolidated Revenues, Company Growth, and Expectations f
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Beasley Broadcast Group, Inc. (NASDAQ:BBGI), Resolute Energy Corporation...
Oct 30, 2018 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital...
Oct 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market opens on Tuesday, October 30th.  IRADIMED management will host a conference call the same day beginning at...
Sep 11, 2018 07:00 am ET
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced receipt of regulatory clearance from the Japanese Ministry of Health Labor Welfare for the IRADIMED...
Jul 31, 2018 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2018 Financial Results
IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is designed to be safe for...
Jul 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 Second Quarter Financial Results Conference Call on July 31st
IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 second quarter financial results before the market opens on Tuesday, July 31st. IRADIMED management will host a conference call the same day beginning at...
Apr 16, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2018 First Quarter Financial Results Conference Call on April 30th
WINTER SPRINGS, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, April 30th.  IRADIMED management will host a conference...
Mar 05, 2018 07:00 am ET
IRADIMED CORPORATION to Present at 30th Annual Roth Conference
WINTER SPRINGS, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer, will present at the 30th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled to...
Feb 06, 2018 08:45 am ET
iRadimed Corp to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 6, 2018 / iRadimed Corp (NASDAQ: IRMD) will be discussing their earnings results in their Q4 Earnings Call to be held on February 6, 2018 at 11:00 AM Eastern Time.
Feb 06, 2018 07:00 am ET
IRADIMED CORPORATION Announces Fourth Quarter 2017 Financial Results
WINTER SPRINGS, Fla., Feb. 06, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of non-magnetic intravenous (“IV”) infusion pump systems that...
Jan 26, 2018 07:00 am ET
IRADIMED CORPORATION to Hold 2017 Fourth Quarter Financial Results Conference Call on February 6th
WINTER SPRINGS, Fla., Jan. 26, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, February 6th.  IRADIMED management will host a conference...
Jan 22, 2018 07:00 am ET
IRADIMED CORPORATION Announces 2018 Annual and First Quarter Financial Guidance
WINTER SPRINGS, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (MRI) medical devices and the only known provider of a non-magnetic intravenous (IV) infusion pump system...
Sep 18, 2017 03:00 pm ET
IRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference
WINTER SPRINGS, Fla., Sept. 18, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference in New York, NY.  Mr. Susi and Mr. Scott are scheduled to present on Tuesday, September 26th at 3:25 pm Eastern Time....
Jul 17, 2017 10:30 am ET
IRADIMED CORPORATION to Hold 2017 Second Quarter Financial Results Conference Call on July 28th
WINTER SPRINGS, Fla., July 17, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 second quarter financial results before the market opens on Friday, July 28th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Mar 01, 2017 07:00 am ET
IRADIMED CORPORATION to Present at 29th Annual Roth Conference
WINTER SPRINGS, Fla., March 01, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the 29th Annual Roth Conference in Laguna Niguel, CA.  Mr. Susi and Mr. Scott are scheduled to present on Monday, March 13th at 11:00 am Pacific Time (2:00 pm Eastern Time)....
Oct 28, 2016 07:00 am ET
IRADIMED CORPORATION Announces Third Quarter 2016 Financial Results
Reports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14 WINTER SPRINGS, Fla., Oct. 28, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three and nine months ended September 30, 2016. ...
Oct 18, 2016 08:30 am ET
IRADIMED CORPORATION to Hold 2016 Third Quarter Financial Results Conference Call on October 28th
WINTER SPRINGS, Fla., Oct. 18, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 third quarter financial results before the market opens on Friday, October 28th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Oct 04, 2016 06:55 am ET
IRADIMED CORPORATION Revises Financial Guidance for the Third Quarter and Full Year 2016
WINTER SPRINGS, Fla., Oct. 04, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today revised its third quarter and full year 2016 financial guidance....
Jul 29, 2016 07:00 am ET
IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results
Revenue grows 29.7% compared to the same quarter last yearReports second quarter 2016 GAAP diluted EPS of $0.19 and non-GAAP diluted EPS of $0.24Increases full year 2016 non-GAAP earnings guidanceSubmits patient vital signs monitor 510(k) application to FDA for review WINTER SPRINGS, Fla., July 29, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three and six months en...
Jul 15, 2016 08:30 am ET
IRADIMED CORPORATION to Hold 2016 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 15, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 second quarter financial results before the market opens on Friday, July 29th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions....
Jun 28, 2016 04:00 pm ET
IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board of Directors
WINTER SPRINGS, Fla., June 28, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Jonathan Kennedy has been appointed to the Company’s Board of Directors....
Jun 14, 2016 04:00 pm ET
IRADIMED CORPORATION Announces Election of Roger Susi as Chairman of the Board
WINTER SPRINGS, Fla., June 14, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that its Board of Directors voted unanimously to appoint current President and Chief Executive Officer, Roger Susi, as Chairman of the Board.  The appointment was effective as of the Annual Shareholders’ Meeting held on June 10, 2016.  Mr. Susi’s appointment is the result of the resignation of Jim Hawkins from the Company’s Board of Directors that was effective as of the date of the Annual Shareholders’ Meeting. ...
Jun 09, 2016 07:00 am ET
IRADIMED CORPORATION Provides Regulatory Update
WINTER SPRINGS, Fla., June 09, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD)...
Apr 29, 2016 07:00 am ET
IRADIMED CORPORATION Announces First Quarter 2016 Financial Results
Revenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance WINTER SPRINGS, Fla., April 29, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended March 31, 2016. ...